Skip to main content
Livermore
Livermore
ZHEN

Axogen, Inc.

AXGN
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0000805928

In the last 90 days, Axogen, Inc. insiders filed 0 open-market purchases and 4 sales; 253 institutions reported holding it in 13F filings for Q2 2026, worth $2.43B in total; no superinvestor holds it.

Holders of 5% or more of AXGN

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Axogen, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of AXGN
HolderLatest formStakeChangeFirst filedLatest filingFiling
First Light Asset Management, LLC13G/A12.88%5.94M shares+2.37 ppfrom 10.51%Jan 8, 20252 filingsNov 14, 2025SEC
Morgan Stanley13G/A5.30%2.33M shares–Feb 3, 20251 filingFeb 3, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

5 Schedule 13D and 13G filings on Axogen, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on AXGN
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 14, 20254:35 PM ETFirst Light Asset Management, LLCand 1 other13G/A12.88%5.94M shares+2.37 ppfrom 10.51%Sep 30, 2025SEC
May 15, 20254:42 PM ETArrowMark Colorado Holdings LLC13G/A3.59%1.59M shares–Below 5%Mar 31, 2025SEC
May 2, 20255:00 PM ETSoleus Capital Master Fund, L.P.and 5 others13G/A3.70%1.45M shares–Below 5%Mar 31, 2025SEC
Feb 3, 20253:33 PM ETMorgan Stanleyand 1 other13G/A5.30%2.33M shares–Dec 31, 2024SEC
Jan 8, 20254:35 PM ETFirst Light Asset Management, LLCand 1 other13G/A10.51%4.63M shares–Dec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Axogen, Inc. shares.

No Form 144 notices for Axogen, Inc. are on file.